Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6408

Dipropylene glycol: Target Organs and Levels of Evidence for TR-511

Toxicology and Carcinogenesis Studies of Dipropylene Glycol (CASRN 25265-71-8) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Dipropylene glycol
25265-71-8
Dosed-Water
R&M: 0, 0.5, 1.0, 2.0, 4.0 OR 8.0 % (10/S/S)
A.D. Little Life Science Laboratories

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Dipropylene glycol
25265-71-8
09/05/2002 Dosed-Water
R: 0, 0.25, 1.0, OR 4.0% M: 0, 1.0, 2.0, OR 4.0%; 50/SEX/DOSE
Battelle Columbus Laboratory

Levels of Evidence

Male Mice: No Evidence
Female Mice: No Evidence


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Dipropylene glycol
25265-71-8
09/05/2002 Dosed-Water
R: 0, 2,500, 10,000, or 10,000 ppm; M: 0, 10,000, 20,000 or 40,000 ppm; 50/SEX/DOSE
Battelle Columbus Laboratory

Levels of Evidence

Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • KIDNEY: INCREASED SEVERITY OF NEPHROPATHY
  • LIVER: INFLAMMATION, FOCAL, HISTIOCYTIC AND GRANULOMATOUS; BILE DUCT HYPERPLASIA
  • NASAL CAVITY: (OLFACTORY EPITHELIUM) ATROPHY; DEGENERATION; THROMBOSIS
Female Rats: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • LIVER: BILE DUCT HYPERPLASIA
  • NASAL CAVITY: OLFACTORY EPITHELIUM DEGENERATION